Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Yirun Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Yirun Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yirun Biotechnology
Developer of concentrate series product focusing on microbial enzymes. The company's products are crops and Chinese herbal medicines as fermentation raw materials, providing clients with a variety of ecological chain probiotic strains.
- Sector
- Materials and Resources
- HQ
- Changsha, China
- Founded
- 2015
- Ownership
- Privately Held (backing)
Yirun Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yirun Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yirun Biotechnology in its N-PORT filings yet. We sweep new filings monthly.